Global Pharmaceutical Blockchain Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Pharmaceutical Blockchain Market Research Report 2024
The global Blockchain in Pharmaceutical market size is projected to reach US$ 30519 million by 2026, from US$ 1010.2 million in 2019, at a CAGR of 72.77% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Blockchain in Pharmaceutical market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Blockchain in Pharmaceutical market in terms of revenue.
According to MRAResearch’s new survey, global Pharmaceutical Blockchain market is projected to reach US$ 2214.8 million in 2033, increasing from US$ 1744 million in 2022, with the CAGR of 3.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pharmaceutical Blockchain market research.
Among the different types of blockchain in pharmaceutical, the private blockchain held the maximum market share with about 91% in 2019.
For applications of the blockchain in pharmaceutical, the supply chain logistics is the largest segment with a market share of nearly 69% in 2019.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Pharmaceutical Blockchain market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Chronicled Inc.
Doc.AI
Embleema
Factom Inc.
FarmaTrust
Guardtime Federal
Hashed Health
IBM Corporation
Medicalchain
Microsoft Corporation
Organizations Mentioned
American Society of Clinical Oncology (ASCO)
Association of Clinical Trials Organizations (ACTO)
Castor EDC
Clinical Supplies Management Holdings, Inc.
ClinicalTrials.gov
Medpace
N-SIDE
Quanticate
Society for Clinical Trials
Segment by Type
Public
Private
Supply Chian Management
Clinical Data Exchange and Interoperability
Drug Development
Clinical Trials
Internet of Medical Things (IOMT)& Cyber Security
Other Applications
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Pharmaceutical Blockchain report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Blockchain in Pharmaceutical market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Blockchain in Pharmaceutical market in terms of revenue.
According to MRAResearch’s new survey, global Pharmaceutical Blockchain market is projected to reach US$ 2214.8 million in 2033, increasing from US$ 1744 million in 2022, with the CAGR of 3.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pharmaceutical Blockchain market research.
Among the different types of blockchain in pharmaceutical, the private blockchain held the maximum market share with about 91% in 2019.
For applications of the blockchain in pharmaceutical, the supply chain logistics is the largest segment with a market share of nearly 69% in 2019.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Pharmaceutical Blockchain market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chronicled Inc.
Doc.AI
Embleema
Factom Inc.
FarmaTrust
Guardtime Federal
Hashed Health
IBM Corporation
Medicalchain
Microsoft Corporation
Organizations Mentioned
American Society of Clinical Oncology (ASCO)
Association of Clinical Trials Organizations (ACTO)
Castor EDC
Clinical Supplies Management Holdings, Inc.
ClinicalTrials.gov
Medpace
N-SIDE
Quanticate
Society for Clinical Trials
Segment by Type
Public
Private
Segment by Application
Supply Chian Management
Clinical Data Exchange and Interoperability
Drug Development
Clinical Trials
Internet of Medical Things (IOMT)& Cyber Security
Other Applications
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Pharmaceutical Blockchain report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source